Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from Genomic Signatures of Poor Prognosis in Merkel Cell Carcinoma: A Single-Institution Prospective Study
  1. Home
  2. Publications
  3. Supplementary Table S1 from Genomic Signatures of Poor Prognosis in Merkel Cell Carcinoma: A Single-Institution Prospective Study

Supplementary Table S1 from Genomic Signatures of Poor Prognosis in Merkel Cell Carcinoma: A Single-Institution Prospective Study

Authors:
  • JSJoshua D. Smith
    Joshua D. Smith
  • ABApurva D. Bhangale
    Apurva D. Bhangale
  • WGWenjin Gu
    Wenjin Gu
  • CBCollin Brummel
    Collin Brummel
  • EGElizabeth Gensterblum-Miller
    Elizabeth Gensterblum-Miller
  • SMScott McLean
    Scott McLean
  • PHPaul W. Harms
    Paul W. Harms
  • KHKelly L. Harms
    Kelly L. Harms
  • CBChristopher K. Bichakjian
    Christopher K. Bichakjian
  • MSMatthew E. Spector
    Matthew E. Spector
  • RMRyan E. Mills
    Ryan E. Mills
  • JBJ. Chad Brenner
    J. Chad Brenner

Open Access
Publisher website
Google Scholar
  • 3 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1541-7786.30516325
Abstract
Summary of definitive treatment modalities for MCC patients in our cohort, stratified by stage. Data presented as n (%). a Including sentinel lymph node biopsy ± completion lymphadenectomy of regional lymphatic basin.
Keywords
  • CELL CARCINOMA
  • GENOMIC SIGNATURES
  • POOR PROGNOSIS
  • MERKEL CELL
  • PROSPECTIVE STUDY
  • STUDY SUMMARY
  • SUPPLEMENTARY TABLE
  • SINGLE-INSTITUTION PROSPECTIVE
  • MCC PATIENTS
  • DEFINITIVE TREATMENT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.